A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma

NCT05322135 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped PI Request

Conditions

Head and Neck Squamous Cell Carcinoma
Head and Neck Cancer

Interventions

DRUG: 18F-FSPG
DRUG: 11C-Glutamine

Sponsor

M.D. Anderson Cancer Center